about
Optical pumping system design for large production of hyperpolarizedLarge production system for hyperpolarized 129Xe for human lung imaging studiesRecovery index, attentiveness and state of memory after xenon or isoflurane anaesthesia: a randomized controlled trialArgon neuroprotection.Genotoxic effects of anesthetic agents: an update.Theoretical predictions of the spectroscopic parameters in noble-gas molecules: HXeOH and its complex with water.Preconditioning triggered by carbon monoxide (CO) provides neuronal protection following perinatal hypoxia-ischemia.Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial.XENON in medical area: emphasis on neuroprotection in hypoxia and anesthesia.Structural Basis for Xenon Inhibition in a Cationic Pentameric Ligand-Gated Ion ChannelBubbles, gating, and anesthetics in ion channelsAnalgesia and sedation after pediatric cardiac surgery.Cellular signaling pathways and molecular mechanisms involving inhalational anesthetics-induced organoprotection.Renal function following xenon anesthesia for partial nephrectomy-An explorative analysis of a randomized controlled study.Anesthesia, analgesia, and euphoria.Urine analysis concerning xenon for doping control purposes.Xenon anesthesia for all, or only a select few?Simultaneous detection of xenon and krypton in equine plasma by gas chromatography-tandem mass spectrometry for doping control.Modelling of noble anaesthetic gases and high hydrostatic pressure effects in lipid bilayers.Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers.Measuring xenon in human plasma and blood by gas chromatography/mass spectrometry.Xenon Recovery at Room Temperature using Metal-Organic Frameworks.Neonatal hypoxic ischaemic encephalopathy: current and future treatment optionsIs xenon a future neuroprotectant?
P2860
Q27342999-3B7A8CC3-90F7-491F-8000-C500E6449363Q33335477-1550BCF6-4392-4B9D-9B5E-19D3E157CE0EQ33575174-72446270-822F-42BD-8D04-CFBB036BEC97Q33873386-FA7EEE0C-5DA4-4734-9D50-DC7144AE565EQ33905781-D4DA0E23-9BE0-4118-AA8A-53CAF7FF46AAQ33976593-67FED96E-D73A-44E7-9513-2B4D83B67D43Q34404774-91380FA5-C408-45CE-9D08-9419CB1CCC7AQ34506676-A463C32C-7C1A-4B76-A94A-8DA0FD7F3A79Q34570042-9002E83D-9346-4C5F-A6AC-85DAB824FB7BQ35933917-8917F38E-1D72-4CFE-829C-32C6E1D944B3Q36785221-57A35534-9F8A-4C45-B871-86ADDB873C09Q37814476-08C84DF8-EF94-42B2-87C7-A021A74D8E22Q38194488-B4BDAE4E-7B44-4B7B-B08C-D2323B2D6A72Q38673772-840FC1B0-F668-4A32-AAE3-0004E5DFB0A1Q41047689-D2EEFF35-32E6-4A02-8FE6-4044D475E924Q41740386-13DDF191-25FB-4C97-BB3A-7776C719BA14Q47398334-F795E94E-4243-4B9B-8A66-89F7FE02C0A8Q47450107-CBEEF6F4-D340-442F-937D-1FB2810E6CC6Q47758476-898D5326-EAF5-4CC1-BF32-CBED5BF35979Q47842719-E8606DEB-6C54-456F-8D12-4BE22AC19FCFQ47866127-FA13262E-362C-4EA9-9888-E27EB4A0BE9EQ53727699-A094BAA0-0337-471F-8D28-EE48127A6C04Q57405344-65D81189-04B4-4621-A667-CD5F2719D13EQ59134386-FC2C87DB-4284-4C31-9985-2C76D516F9EA
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Xenon: elemental anaesthesia in clinical practice.
@ast
Xenon: elemental anaesthesia in clinical practice.
@en
type
label
Xenon: elemental anaesthesia in clinical practice.
@ast
Xenon: elemental anaesthesia in clinical practice.
@en
prefLabel
Xenon: elemental anaesthesia in clinical practice.
@ast
Xenon: elemental anaesthesia in clinical practice.
@en
P356
P1476
Xenon: elemental anaesthesia in clinical practice.
@en
P2093
Mervyn Maze
Robert D Sanders
P304
P356
10.1093/BMB/LDH034
P50
P577
2004-01-01T00:00:00Z